z-logo
Premium
A combined prognostic factor for improved risk stratification of patients with oral cancer
Author(s) -
Kim KY,
Zhang X,
Kim SM,
Lee BD,
Cha IH
Publication year - 2017
Publication title -
oral diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.953
H-Index - 87
eISSN - 1601-0825
pISSN - 1354-523X
DOI - 10.1111/odi.12579
Subject(s) - multivariate analysis , medicine , multivariate statistics , oncology , stage (stratigraphy) , pathological , univariate , risk factor , t stage , lymph node , univariate analysis , risk stratification , basal cell , resection margin , cancer , gastroenterology , surgery , resection , statistics , biology , paleontology , mathematics
Purpose We aimed to identify a combined prognostic factor for predicting better performance in risk stratification. Materials and Methods We reviewed the clinical and pathological variables of 316 patients with oral squamous cell carcinoma ( OSCC ) who underwent surgery. To identify a combined predictor, principal component analysis ( PCA ) was performed. Results Univariate analysis showed that the independent prognostic variables for overall survival ( OS ) were pathologic T stage (T1 vs T4, HR  = 1.99, 95% CI : = 1.083–3.675, P  = 0.026) and pathologic N stage (N0 vs N2, HR =1.90, 95% CI : = 1.17–3.08, P  = 0.008). In the multivariate analysis, only pathologic T stage was significant ( P  = 0.006 and P  = 0.007); however, the multivariate model was not significant ( P  = 0.191). The multivariate model became significant by including lymph node ratio ( LNR ) instead of pathologic N stage ( P  = 0.0025 in numeric LNR , P  = 0.0007 in categorized LNR ). Also, the performance of prediction model was improved by a combined prognostic factor ( P  = 0.0002). Conclusions The newly identified combined prognostic factor included resection margin, differentiation, and LNR , and they were insignificant factors independently except for LNR . This combined prognostic factor showed a good performance although it did not include molecular markers; therefore, it may be used conveniently for risk stratification of patients with OSCC by combining only clinical information.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here